MACROGENICS, INC.

ABD-DART

Production and product commercialization for third parties of pharmaceuticals and substances, namely, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases;Discovery, research, development, engineering and testing of pharmaceuticals and substances, namely, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases; Providing medical and scientific research information relating to pharmaceutical substances, namely, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases;

BREAKTHROUGH BIOLOGICS, LIFE CHANGING MEDICINES

Production and product commercialization for third parties of pharmaceuticals and substances for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases;BIOLOGICS AND MEDICINE;Discovery, research, and development of pharmaceuticals and substances for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases; Discovery, research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of pharmaceutical and biotechnology fields; Providing medical and scientific research information in the field of pharmaceuticals and biotechnology;

CHANGING MOLECULES INTO MEDICINES

Business development services, namely, assistance in product commercialization for third parties of pharmaceuticals and substances for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases;MEDICINES;Production, namely, pharmaceutical product and drug development; Drug discovery and research, and development of pharmaceuticals and substances in the nature of polypeptides, particularly antibodies and antibody derivatives, for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases; Drug discovery and research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of pharmaceutical and biotechnology products; Providing medical and scientific research information in the field of pharmaceuticals and biotechnology;

DART

Pharmaceutical preparations and substances, namely, polypeptides, particularly antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases;

DART

Production and product commercialization for third parties of pharmaceuticals and substances, namely, bispecific and multi-specific, antibody-based molecules, that bind to two or more targets, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases;

DEVELOPING BREAKTHROUGH BIOLOGICS, LIFE-CHANGING MEDICINES

New product commercialization services, namely, commercialization for third parties of pharmaceuticals and substances for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases;Discovery, research, and development of pharmaceuticals and substances for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases; Discovery, research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of pharmaceutical and biotechnology fields; Providing medical and scientific research information in the field of pharmaceuticals and biotechnology;

EUTEPIA

pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, anxiety, bone and skeletal diseases and disorders, blood disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, diabetes, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, liver diseases and disorders, kidney diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, reproductive system diseases and disorders, urological disorders, dyslipidemia, sleep disorders, migraines, metabolic diseases and disorders, and multiple sclerosis; antipsychotics; antidepressants; Veterinary preparations for companion animals in the treatment of weight loss, obesity, urine spraying, chronic pain, gastrointestinal disorders, neurodegenerative disorders, parasitic infestations, neurological disorders, anxiety, hypertension, dermatitis, cancer, anemia associated with chronic renal failure, fleas, pain associated with orthopedic and soft tissue surgery, chronic kidney disease, and emesis; preparations for destroying vermin, namely, insecticides for use with livestock and livestock premises; veterinary preparations for the treatment, control and symptomatic relief of infectious and metabolic diseases of livestock; dietary food supplements for animals; antibacterial pharmaceuticals; production improvement for livestock, namely, medicated feed and medicated water additives for livestock; diagnostic agents, preparations and substances to identify pathogens or residues of biological interest for veterinary use;

EUTEPPIA

pharmaceutical preparations for use in the treatment of diabetes;The wording EUTEPPIA has no meaning in a foreign language.;

EUTEPPIA

pharmaceutical preparations for use in the treatment of rheumatoid arthritis; pharmaceutical preparations for use in the treatment of Crohn's disease; pharmaceutical preparations for use in the treatment of ulcerative colitis;

EUTEPYA

pharmaceutical preparations for use in the treatment of diabetes;The wording EUTEPYA has no meaning in a foreign language.;

EUTEPYA

pharmaceutical preparations for use in the treatment of rheumatoid arthritis; pharmaceutical preparations for use in the treatment of Crohn's disease; pharmaceutical preparations for use in the treatment of ulcerative colitis;

FC-DART

Pharmaceutical preparations and substances, namely, polypeptides, particularly antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases;

FC-DART

Production and product commercialization for third parties of pharmaceuticals and substances, namely, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases;Discovery, research, development, engineering and testing of pharmaceuticals and substances, namely, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases; Providing medical and scientific research information relating to pharmaceutical substances, namely, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases;

I-DART

Pharmaceutical preparations and substances, namely, polypeptides, particularly antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases;

I-DART

Production and product commercialization for third parties of pharmaceuticals and substances, namely, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases;Discovery, research, development, engineering and testing of pharmaceuticals and substances, namely, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases; Providing medical and scientific research information relating to pharmaceutical substances, namely, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases;

IG-DART

Pharmaceutical preparations and substances, namely, polypeptides, particularly antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases;

IG-DART

Production and product commercialization for third parties of pharmaceuticals and substances, namely, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases;Discovery, research, development, engineering and testing of pharmaceuticals and substances, namely, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases; Providing medical and scientific research information relating to pharmaceutical substances, namely, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases;

MACROGENICS

Production and product commercialization for third parties of pharmaceuticals and substances for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, [ allergies, ] cancer, and infectious diseases;Discovery, research, and development of pharmaceuticals and substances for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, [ allergies, ] cancer, and infectious diseases; Discovery, research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of pharmaceutical and biotechnology fields; Providing medical and scientific research information in the field of pharmaceuticals and biotechnology;

MACROGENICS

The mark consists of a check mark symbol, straight line and curved line, and the term MacroGenics. The curved line appears between the letters o and g in the term MacroGenics, the check mark appears above the letter m and the straight line below the letter m.;MACRO GENICS INCORPORATION;Color is not claimed as a feature of the mark.;Production and product commercialization for third parties of pharmaceuticals and substances for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, [ allergies, ] cancer, and infectious diseases;Discovery, research, and development of pharmaceuticals and substances for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, [allergies, ] cancer, and infectious diseases; Discovery, research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of pharmaceutical and biotechnology fields; Providing medical and scientific research information in the field of pharmaceuticals and biotechnology;